Rosuvastatine (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rosuvastatine" in French language version.

refsWebsite

Global rank French rank

3nejm.org

2,374^th place

298^th place

1qmul.ac.uk

1,735^th place

168^th place

1nih.gov

4^th place

12^th place

1doi.org

2^nd place

3^rd place

1thelancet.com

2,393^rd place

506^th place

1oxfordjournals.org

1,389^th place

508^th place

1nature.com

234^th place

147^th place

1sante.fr

8,603^rd place

517^th place

doi.org

dx.doi.org

(en) Fellstrom BC, Jardine AG, et al., « Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis », N. Engl. J. Med., vol. 360, n^o 14,‎ avril 2009, p. 1395–1407 (PMID 19332456, DOI 10.1056/NEJMoa0810177, lire en ligne)

nature.com

(en) Biologic drugs set to top 2012 sales, Nature Medicine, 2012;18,636

nejm.org

content.nejm.org

(en) Ridker PM, Danielson E, Fonseca FAH et als. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 2008;359:2195-2207
(en) Hlatky MA, Expanding the orbit of primary prevention — Moving beyond JUPITER, N Eng J Med, 2008;359:2280-2282
(en) Fellstrom BC, Jardine AG, et al., « Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis », N. Engl. J. Med., vol. 360, n^o 14,‎ avril 2009, p. 1395–1407 (PMID 19332456, DOI 10.1056/NEJMoa0810177, lire en ligne)

nih.gov

ncbi.nlm.nih.gov

(en) Fellstrom BC, Jardine AG, et al., « Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis », N. Engl. J. Med., vol. 360, n^o 14,‎ avril 2009, p. 1395–1407 (PMID 19332456, DOI 10.1056/NEJMoa0810177, lire en ligne)

oxfordjournals.org

eurheartj.oxfordjournals.org

(en) Maggioni AP, Fabbri G, Lucci D, Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial, Eur Heart J, 2009;30:2327-2336

qmul.ac.uk

chem.qmul.ac.uk

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

sante.fr

ansm.sante.fr

Agence nationale de sécurité du médicament, Analyses des ventes des médicaments en France en 2012

thelancet.com

(en) Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ, Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial, Lancet, 2012;380:565-571